Jazz Pharmaceuticals (JAZZ) Q3 Earnings and Revenues Top Estimates

Jazz Pharmaceuticals (JAZZ) came out with quarterly earnings of $6.61 per share, beating the Zacks Consensus Estimate of$ 5.47 per share. This compares to earnings of $4.84 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 20.84%. A quarter ago, it was expected that this drugmaker would post earnings of$ 4.68 per share when it actually produced earnings of $5.30, delivering a surprise of 13.25%.Over the last four quarters, the c ...